These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3090857)

  • 1. Susceptibility testing with disc diffusion for new cephalosporins: pre-diffusion revisited.
    Frimodt-Møller N; Hvass E; Højbjerg T; Møller S; Mortensen I; Thomsen VF
    Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):159-66. PubMed ID: 3090857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
    Frimodt-Møller N; Højbjerg T; Hvass E; Møller S; Mortensen I; Thomsen VF
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):181-8. PubMed ID: 3929558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance Group.
    Fuchs PC; Barry AL; Brown SD
    Diagn Microbiol Infect Dis; 1996 Apr; 24(4):213-9. PubMed ID: 8831036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
    Barry AL; Brown SD; Fuchs PC
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of agar diffusion tests and serial dilution tests. Demonstration of regression lines for gentamycin].
    Wahlig H; Hameister W; Naumann P; Linzenmeier G; Neussel H
    Int J Clin Pharmacol; 1973 Jul; 7(4):328-39. PubMed ID: 4199252
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical features and antimicrobial resistance profiles of important Enterobacteriaceae pathogens in Guangzhou representative of Southern China, 2001-2015.
    Xie J; Peters BM; Li B; Li L; Yu G; Xu Z; Shirtliff ME
    Microb Pathog; 2017 Jun; 107():206-211. PubMed ID: 28365324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different activity of penicillins and cephalosporins on enterococci.
    Fontana R; Rossi L; Gesu GP; Maresu F; Satta G; Stefani S
    Chemioterapia; 1987 Jun; 6(2 Suppl):60-1. PubMed ID: 3151354
    [No Abstract]   [Full Text] [Related]  

  • 10. Criteria for the assessment of susceptibility to ceftazidime using the disc diffusion procedure.
    Grimm H
    Infection; 1983; 11 Suppl 1():S35-8. PubMed ID: 6339416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C; Poiată A; Bădicuţ I; Teodor A; Luca V; Grigore L; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):595-8. PubMed ID: 14756068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values].
    Cluzel M; Chanal M; Sirot D; Sirot J; Cluzel R
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):473-6. PubMed ID: 3937122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of beta-lactam and inhibitor combinations in a diffusion chamber model in rabbits.
    Georgopoulos A; Buxbaum A; Graninger W
    J Antimicrob Chemother; 1999 Apr; 43(4):497-501. PubMed ID: 10350378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
    Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potencies of ceftriaxone and cefotaxime in a single chamber pharmacokinetic system simulating their in vivo half-lives.
    Unowsky J; Sattler J; Patel IH
    Chemotherapy; 1989; 35(5):338-44. PubMed ID: 2676404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
    Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
    Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of interpretive breakpoints for ceftazidime disc-diffusion susceptibility testing using single-strain regression analysis.
    Petersson AC; Kronvall G
    Acta Pathol Microbiol Immunol Scand B; 1985 Aug; 93(4):289-96. PubMed ID: 3901667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the effect of hexetidine in vitro].
    Linzenmeier G
    Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.